• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项全州范围的芬太尼持有法的实施与阿片类药物相关的过量死亡

Implementation of a Statewide Fentanyl Possession Law and Opioid-Related Overdose Deaths.

作者信息

Jurecka Cole, Adams Joella, Padmanabhan Pranav, Glanz Jason, Christine Paul, Guan Xiaoyu, Kline Danielle, Binswanger Ingrid, Barocas Joshua

机构信息

Division of General Internal Medicine, University of Colorado School of Medicine, Aurora.

RTI International, Durham, North Carolina.

出版信息

JAMA Health Forum. 2025 Aug 1;6(8):e252654. doi: 10.1001/jamahealthforum.2025.2654.

DOI:10.1001/jamahealthforum.2025.2654
PMID:40748547
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12317351/
Abstract

IMPORTANCE

In 2022, Colorado passed legislation making possession of small amounts of fentanyl, a high-potency synthetic opioid, a felony. Whether the Colorado law affected opioid overdose fatalities and whether those effects differed by racial and ethnic subgroups is unknown.

OBJECTIVE

To estimate the association between the change in criminal penalties for fentanyl possession with opioid-related overdose deaths (OODs) in Colorado.

DESIGN, SETTING, AND POPULATION: Serial cross-sectional study comparing OODs among adults (≥18 years) who died of an overdose and population estimates before and after Colorado House Bill (HB) 22-1326 was enacted in July 2022 (January 2018-November 2023) using autoregressive integrated moving averages (ARIMA) model time series forecasting. Monthly OOD rates per 100 000 residents were calculated using state population estimates from the American Community Survey 5-Year Data and the Colorado Department of Local Affairs State Demography Office. Overdose death rates were calculated separately by racial and ethnic group (Hispanic, non-Hispanic Black, and non-Hispanic White). Data were analyzed from January 2018 to 2023.

EXPOSURE

Enactment of HB 22-1326 changed the legal penalty for possession of any drug weighing 1 g to 4 g that contained any amount of fentanyl from a misdemeanor to a level-4 drug felony punishable by up to 180 days in jail and up to 2 years of probation.

MAIN OUTCOME

The difference between expected and observed OOD rates following the enactment of increased criminal penalties.

RESULTS

A total of 7099 OODs were analyzed (1798 Hispanic [25.3%], 451 Non-Hispanic Black [6.4%], and 4170 Non-Hispanic White [58.7%], 680 other [9.5%] and not included in the race and ethnicity categories). OODs increased across the study period in Colorado from 20.46 per 100 000 adults in January 2018 to 37.78 per 100 000 adults in November 2023. Among different racial and ethnic groups, the non-Hispanic Black population had the highest increase in OODs (9.3 per 100 000 in 2018 to 56.9 per 100 000 in 2023) followed by the Hispanic population. There was no difference between the observed and expect overdose deaths for the overall population following the enactment of HB 22-1326. However, there were significant increases in 4 of 13 months after policy implementation among the non-Hispanic Black population.

CONCLUSIONS AND RELEVANCE

The results of this serial cross-sectional study suggest that increased criminal penalties for fentanyl possession did not change preexisting trends of OODs in Colorado and may have been associated with an increase in opioid overdoses in the Black population. These results should be interpreted in light of increasing opioid overdose rates in Black populations nationally during the study period.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1070/12317351/94020ee98cd6/jamahealthforum-e252654-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1070/12317351/e33fd753f9ba/jamahealthforum-e252654-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1070/12317351/94020ee98cd6/jamahealthforum-e252654-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1070/12317351/e33fd753f9ba/jamahealthforum-e252654-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1070/12317351/94020ee98cd6/jamahealthforum-e252654-g002.jpg
摘要

重要性

2022年,科罗拉多州通过立法,将持有少量芬太尼(一种高效合成阿片类药物)定为重罪。科罗拉多州的这项法律是否影响了阿片类药物过量致死情况,以及这些影响在不同种族和族裔亚群体中是否存在差异尚不清楚。

目的

评估科罗拉多州持有芬太尼刑事处罚变化与阿片类药物相关过量死亡(OODs)之间的关联。

设计、背景和人群:采用自回归积分滑动平均(ARIMA)模型时间序列预测进行的系列横断面研究,比较2022年7月科罗拉多州众议院法案(HB)22 - 1326颁布前后(2018年1月至2023年11月)死于过量用药的成年人(≥18岁)中的OODs情况以及人口估计数。每10万居民的月度OOD率使用美国社区调查5年数据和科罗拉多州地方事务部州人口统计办公室的州人口估计数计算得出。过量死亡率按种族和族裔群体(西班牙裔、非西班牙裔黑人、非西班牙裔白人)分别计算。数据于2018年1月至2023年进行分析。

暴露因素

HB 22 - 1326的颁布将持有任何含有任何数量芬太尼且重量为1克至4克的毒品的法律处罚从轻罪改为4级毒品重罪,最高可判处180天监禁和2年缓刑。

主要结局

刑事处罚加重颁布后预期和观察到的OOD率之间的差异。

结果

共分析了7099例OODs(1798例西班牙裔[25.3%],451例非西班牙裔黑人[6.4%],4170例非西班牙裔白人[58.7%],680例其他[9.5%],未纳入种族和族裔类别)。在研究期间,科罗拉多州的OODs从2018年1月每10万成年人中的20.46例增加到2023年11月的每10万成年人中的37.78例。在不同种族和族裔群体中,非西班牙裔黑人人口的OODs增加最多(从2018年每10万中的9.3例增加到2023年每10万中的56.9例),其次是西班牙裔人口。HB 22 - 1326颁布后,总体人群中观察到的和预期的过量死亡之间没有差异。然而,在政策实施后的13个月中有4个月,非西班牙裔黑人人口中的过量死亡显著增加。

结论与意义

这项系列横断面研究的结果表明,对持有芬太尼加重刑事处罚并未改变科罗拉多州OODs的原有趋势,且可能与黑人人口中阿片类药物过量增加有关。鉴于研究期间全国黑人人口中阿片类药物过量率不断上升应结合这一情况来解释这些结果。

相似文献

1
Implementation of a Statewide Fentanyl Possession Law and Opioid-Related Overdose Deaths.一项全州范围的芬太尼持有法的实施与阿片类药物相关的过量死亡
JAMA Health Forum. 2025 Aug 1;6(8):e252654. doi: 10.1001/jamahealthforum.2025.2654.
2
Disparities by Sex and Race and Ethnicity in Death Rates Due to Opioid Overdose Among Adults 55 Years or Older, 1999 to 2019.1999 年至 2019 年,55 岁及以上成年人因阿片类药物过量导致的死亡率存在性别、种族和民族差异。
JAMA Netw Open. 2022 Jan 4;5(1):e2142982. doi: 10.1001/jamanetworkopen.2021.42982.
3
Surveillance for Violent Deaths - National Violent Death Reporting System, 48 States, the District of Columbia, and Puerto Rico, 2020.暴力死亡监测 - 全国暴力死亡报告系统,2020 年,48 个州、哥伦比亚特区和波多黎各。
MMWR Surveill Summ. 2023 May 26;72(5):1-38. doi: 10.15585/mmwr.ss7205a1.
4
Surveillance for Violent Deaths - National Violent Death Reporting System, 50 States, the District of Columbia, and Puerto Rico, 2022.暴力死亡监测——2022年全国暴力死亡报告系统,50个州、哥伦比亚特区和波多黎各
MMWR Surveill Summ. 2025 Jun 12;74(5):1-42. doi: 10.15585/mmwr.ss7405a1.
5
Law Enforcement Drug Seizures and Opioid-Involved Overdose Mortality.执法部门的毒品查获量与阿片类药物相关的过量死亡率
JAMA Netw Open. 2025 Mar 3;8(3):e251158. doi: 10.1001/jamanetworkopen.2025.1158.
6
Educational Attainment and US Drug Overdose Deaths.受教育程度与美国药物过量死亡人数
JAMA Health Forum. 2023 Oct 6;4(10):e233274. doi: 10.1001/jamahealthforum.2023.3274.
7
Racial and ethnic disparities in fecundability: a North American preconception cohort study.生育力方面的种族和族裔差异:一项北美孕前队列研究。
Hum Reprod. 2025 Apr 17. doi: 10.1093/humrep/deaf067.
8
How Did Black and Hispanic Orthopaedic Applicants and Residents Compare to General Surgery Between 2015 and 2022?2015 年至 2022 年,黑人和西班牙裔骨科申请人和住院医师与普通外科相比如何?
Clin Orthop Relat Res. 2024 Aug 1;482(8):1361-1370. doi: 10.1097/CORR.0000000000003069. Epub 2024 Apr 4.
9
Communities That HEAL Intervention and Mortality Including Polysubstance Overdose Deaths: A Randomized Clinical Trial.社区康复干预与死亡率:包括多药物过量死亡的随机临床试验。
JAMA Netw Open. 2024 Oct 1;7(10):e2440006. doi: 10.1001/jamanetworkopen.2024.40006.
10
Generating Timely Estimates of Overdose Deaths for the US Using Urine Drug Test Data.利用尿液药物检测数据及时估算美国的过量用药死亡人数。
JAMA Netw Open. 2025 Jun 2;8(6):e2514402. doi: 10.1001/jamanetworkopen.2025.14402.

本文引用的文献

1
Drug Decriminalization, Fentanyl, and Fatal Overdoses in Oregon.药物非刑罪化、芬太尼与俄勒冈州的致命过量用药
JAMA Netw Open. 2024 Sep 3;7(9):e2431612. doi: 10.1001/jamanetworkopen.2024.31612.
2
Routes of Drug Use Among Drug Overdose Deaths - United States, 2020-2022.药物滥用死亡者的用药途径 - 美国,2020-2022 年。
MMWR Morb Mortal Wkly Rep. 2024 Feb 15;73(6):124-130. doi: 10.15585/mmwr.mm7306a2.
3
Racial/ethnic disparities in opioid overdose prevention: comparison of the naloxone care cascade in White, Latinx, and Black people who use opioids in New York City.
种族/民族差异与阿片类药物过量预防:纽约市使用阿片类药物的白种人、拉丁裔和非裔人群中纳洛酮护理级联的比较。
Harm Reduct J. 2023 Feb 25;20(1):24. doi: 10.1186/s12954-023-00736-7.
4
Understanding Racial Inequities in the Implementation of Harm Reduction Initiatives.理解减少伤害倡议实施中的种族不平等现象。
Am J Public Health. 2022 Apr;112(S2):S173-S181. doi: 10.2105/AJPH.2022.306767.
5
Interrupted time series analysis using autoregressive integrated moving average (ARIMA) models: a guide for evaluating large-scale health interventions.使用自回归求和移动平均 (ARIMA) 模型的中断时间序列分析:评估大规模卫生干预措施的指南。
BMC Med Res Methodol. 2021 Mar 22;21(1):58. doi: 10.1186/s12874-021-01235-8.
6
Buprenorphine Treatment Divide by Race/Ethnicity and Payment.美沙酮治疗按种族/民族和支付方式划分。
JAMA Psychiatry. 2019 Sep 1;76(9):979-981. doi: 10.1001/jamapsychiatry.2019.0876.
7
Structural racism and health inequities in the USA: evidence and interventions.美国的结构性种族主义和健康不平等:证据与干预。
Lancet. 2017 Apr 8;389(10077):1453-1463. doi: 10.1016/S0140-6736(17)30569-X.
8
Box-Jenkins modelling in medical research.医学研究中的Box-Jenkins建模
Stat Methods Med Res. 1996 Mar;5(1):3-22. doi: 10.1177/096228029600500102.